Shenzhen Police Uncover Counterfeit ALIBARBAR Vape Case Worth Tens of Millions

Nov.18.2024
Shenzhen Police Uncover Counterfeit ALIBARBAR Vape Case Worth Tens of Millions
Shenzhen police, in collaboration with the State Tobacco Monopoly Administration, successfully cracked a major case involving counterfeit ALIBARBAR vapes.

Statement:

On November 22, 2Firsts received a letter from Shenzhen Xiyue Intelligent Technology Manufacturing Co., Ltd. The letter stated that the products shown in the original and counterfeit comparison images in the article "ALIBARBAR Counterfeit Case," first published on sznews were not produced by the company. However, the vape production license number displayed in the images belongs to the company and is suspected of being misappropriated.

 

Since sznews has removed the images, 2Firsts has also deleted them. This statement is issued for clarification.


Shenzhen police and the State Tobacco Monopoly Administration seized tens of thousands of counterfeit ALIBARBAR vapes worth millions, cracking a major case and targeting illegal counterfeit sales, sznews reported on November 15.

 

Shenzhen Police Uncover Counterfeit ALIBARBAR Vape Case Worth Tens of Millions
Crime scene | Image source: sznews

 

Law enforcement in Shenzhen conducted simultaneous raids across multiple locations in one district, shutting down three counterfeit vape production and sales operations. The raids resulted in the seizure of tens of thousands of fake ALIBARBAR vapes, along with manufacturing equipment, raw materials, and packaging materials.

 

Shenzhen Police Uncover Counterfeit ALIBARBAR Vape Case Worth Tens of Millions
Scene of the crime | Image source: sznews

 

During interrogation, the suspects confessed to the crimes of producing and selling counterfeit vapes. They admitted to manufacturing large quantities of fake vapes for high profits and distributing them to overseas markets. The case is currently under further investigation.

 

Shenzhen Police Uncover Counterfeit ALIBARBAR Vape Case Worth Tens of Millions
Crime scene | Image source: sznews

 

Shenzhen police announced their commitment to cracking down on counterfeit production and sales, working closely with the State Tobacco Monopoly Administration and other authorities to protect consumer rights. 

 

They also advised consumers to buy vape products only from official channels, warning that using counterfeit products could lead to serious health risks.

Retail Case Study | Wisconsin Vape Market One Year After New Regulations: Johnny Vapes Reports 80% Sales Decline as Consumers Shift Online and Across State Lines
Retail Case Study | Wisconsin Vape Market One Year After New Regulations: Johnny Vapes Reports 80% Sales Decline as Consumers Shift Online and Across State Lines
According to WNCY on August 24, 2026, some independent vape retailers in Wisconsin say they have faced significant business pressure one year after new vape regulations took effect. Johnny Vapes, a retailer operating in northeast Wisconsin, said its store count fell from seven locations to four, sales declined by about 80%, and roughly 90% of its inventory was affected. Retailers said some consumers have shifted to online purchases or traveled to neighboring Michigan to buy vape products. The case highlights how local regulations can reshape retail operations, inventory management and consumer purchasing patterns.
Aug.28
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Eleftheria (Ria) Kioupritzi, a biopharmaceutical professional with more than 15 years of experience, has joined Philip Morris International as Director Scientific Affairs within Corporate Affairs. She previously served at Roche as Senior Scientific Communications Director for Neuroscience and Rare Diseases and worked extensively in spinal muscular atrophy. Her earlier career also covered competitive intelligence, clinical and regulatory monitoring, pipeline development and launch preparation. During her time working in Roche's SMA field, Evrysdi passed through several U.S. FDA milestones, including its initial approval, an expanded indication for younger infants and approval of a tablet formulation. Public records do not show that Kioupritzi herself led the FDA submissions.
Sep.22
Product | JT Launches Ploom AURA Glacier White in Japan, Expanding the Device Ecosystem Through Color and Accessories
Product | JT Launches Ploom AURA Glacier White in Japan, Expanding the Device Ecosystem Through Color and Accessories
Japan Tobacco Inc. (JT) has introduced the Ploom AURA Glacier White heated tobacco device in Japan, adding a new color option to the existing Ploom AURA lineup. The device maintains the existing SMART HEATFLOW technology and HEAT SELECT SYSTEM with four heating modes, while expanding the ecosystem through new accessories including front panels, back covers, a car holder and wireless charging covers. The product entered pre-sale in Japan on June 30, 2026, followed by broader retail availability from July 7.
Aug.03
NAS 2026 | FDA CTP Director Says PMTA Pathway Is “Predicated on Tobacco Harm Reduction”
NAS 2026 | FDA CTP Director Says PMTA Pathway Is “Predicated on Tobacco Harm Reduction”
At the 2026 New Approaches Summit in New York, FDA Center for Tobacco Products Director Bret Koplow said the PMTA pathway is “predicated on tobacco harm reduction.” He outlined four CTP priorities: youth prevention, helping adults quit or switch to lower-risk products, improving relative-risk communication, and reducing unauthorized products. Koplow also addressed flavored e-cigarettes, public risk perceptions, industry credibility and efforts to make PMTA reviews more efficient and predictable.
Sep.26
Canada Health Minister Says She Is Not Considering Looser Nicotine Pouch Retail Rules as PMI-Linked Group Pushes for Wider Access
Canada Health Minister Says She Is Not Considering Looser Nicotine Pouch Retail Rules as PMI-Linked Group Pushes for Wider Access
Canadian Health Minister Marjorie Michel says she is not considering loosening retail restrictions on nicotine pouches. Canada regulates pouches containing 4 mg or less of nicotine per unit as non-prescription nicotine replacement therapy and requires newer NRT formats such as pouches to be sold from behind pharmacy counters. Meanwhile, Unsmoke Canada, linked to Philip Morris International's Canadian business, is pushing to allow pouches in convenience stores and other general retail outlets. Health Canada also acknowledges continued unauthorized sales, while recent research shows rising pouch use among Canadian youth aged 16 to 19.
Sep.24
JAMA Issues First U.S. Clinical Guidance on Vaping for Smoking Cessation, Urging Complete Switch From Cigarettes
JAMA Issues First U.S. Clinical Guidance on Vaping for Smoking Cessation, Urging Complete Switch From Cigarettes
JAMA has published a Special Communication offering systematic recommendations for U.S.-based clinicians on the use of nicotine e-cigarettes in adult smoking cessation. Developed by the Harm Reduction Workgroup of the Society for Research on Nicotine and Tobacco’s Treatment Research Network, the paper recommends including e-cigarettes alongside FDA-approved cessation medications in risk-benefit discussions. It cites high-certainty evidence that nicotine e-cigarettes achieve higher quit rates than nicotine replacement therapy and evidence suggesting efficacy comparable to highly effective medications such as varenicline and cytisine. For adults who choose vaping to quit, the authors recommend FDA-authorized products, sufficient nicotine delivery and a rapid, complete transition away from cigarettes rather than prolonged dual use.
Aug.13